date,title,source
Oct-22-18,Protagonist Therapeutics Presents Clinical Data from the PROPEL Study of PTG-100 in Ulcerative Colitis at United European Gastroenterology Week,PR Newswire
Oct-29-18,Protagonist Therapeutics (PTGX) Q3 Earnings Preview: What to Know Ahead of the Release,Zacks
Nov-06-18,"Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-06-18,Protagonist Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,PR Newswire
Nov-06-18,Protagonist Therapeutics Announces Completion of Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200,PR Newswire
Nov-07-18,"Protagonist Therapeutics to Present at the Stifel 2018 Healthcare Conference Wednesday, Nov. 14",PR Newswire
